Literature DB >> 12406810

The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997.

Theodore M Hammett1, Mary Patricia Harmon, William Rhodes.   

Abstract

OBJECTIVES: This study developed national estimates of the burden of selected infectious diseases among correctional inmates and releases during 1997.
METHODS: Data from surveys, surveillance, and other reports were synthesized to develop these estimates.
RESULTS: During 1997, 20% to 26% of all people living with HIV in the United States, 29% to 43% of all those infected with the hepatitis C virus, and 40% of all those who had tuberculosis disease in that year passed through a correctional facility.
CONCLUSIONS: Correctional facilities are critical settings for the efficient delivery of prevention and treatment interventions for infectious diseases. Such interventions stand to benefit not only inmates, their families, and partners, but also the public health of the communities to which inmates return.

Entities:  

Mesh:

Year:  2002        PMID: 12406810      PMCID: PMC1447330          DOI: 10.2105/ajph.92.11.1789

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  20 in total

1.  Making the case for health interventions in correctional facilities.

Authors:  T M Hammett
Journal:  J Urban Health       Date:  2001-06       Impact factor: 3.671

2.  Epidemiology of AIDS in incarcerated persons in the United States, 1994-1996.

Authors:  H D Dean-Gaitor; P L Fleming
Journal:  AIDS       Date:  1999-12-03       Impact factor: 4.177

Review 3.  Correctional health care: a public health opportunity.

Authors:  J B Glaser; R B Greifinger
Journal:  Ann Intern Med       Date:  1993-01-15       Impact factor: 25.391

4.  HIV testing in prisoners: is mandatory testing mandatory?

Authors:  J K Andrus; D W Fleming; C Knox; R O McAlister; M R Skeels; R E Conrad; J M Horan; L R Foster
Journal:  Am J Public Health       Date:  1989-07       Impact factor: 9.308

5.  HIV seroprevalence and the acceptance of voluntary HIV testing among newly incarcerated male prison inmates in Wisconsin.

Authors:  N J Hoxie; J M Vergeront; H R Frisby; J R Pfister; R Golubjatnikov; J P Davis
Journal:  Am J Public Health       Date:  1990-09       Impact factor: 9.308

6.  Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland.

Authors:  D Vlahov; K E Nelson; T C Quinn; N Kendig
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

7.  Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV.

Authors:  C Behrendt; N Kendig; C Dambita; J Horman; J Lawlor; D Vlahov
Journal:  Am J Epidemiol       Date:  1994-05-01       Impact factor: 4.897

8.  HIV prevention in prisons and jails: obstacles and opportunities.

Authors:  S Polonsky; S Kerr; B Harris; J Gaiter; R R Fichtner; M G Kennedy
Journal:  Public Health Rep       Date:  1994 Sep-Oct       Impact factor: 2.792

9.  HIV/AIDS education and prevention programs for adults in prisons and jails and juveniles in confinement facilities--United States, 1994.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1996-04-05       Impact factor: 17.586

10.  Scope of the AIDS epidemic in the United States.

Authors:  P S Rosenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

View more
  153 in total

1.  Risk factors for homelessness and sex trade among incarcerated women: A Structural equation model.

Authors:  Seijeoung Kim; Timothy P Johnson; Samir Goswami; Michael Puisis
Journal:  J Int Womens Stud       Date:  2011-01

2.  Implementing opt-out programs at Los Angeles county jail: a gateway to novel research and interventions.

Authors:  Mark Malek; Alexander R Bazazi; Garrett Cox; Germaine Rival; Jacques Baillargeon; Armidia Miranda; Josiah D Rich
Journal:  J Correct Health Care       Date:  2011-01

3.  Newly identified HIV infections in correctional facilities, United States, 2007.

Authors:  Michelle VanHandel; John F Beltrami; Robin J MacGowan; Craig B Borkowf; Andrew D Margolis
Journal:  Am J Public Health       Date:  2012-03-08       Impact factor: 9.308

4.  The negative binomial process and arrests for drug use.

Authors:  Jon Mark Hirshon; P David Wilson
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

5.  In search of the correct strategy for preventing the spread of HCV infection.

Authors:  M Montella; A Crispo; J Wynn-Bellezza
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 6.  Addressing the "risk environment" for injection drug users: the mysterious case of the missing cop.

Authors:  Scott Burris; Kim M Blankenship; Martin Donoghoe; Susan Sherman; Jon S Vernick; Patricia Case; Zita Lazzarini; Stephen Koester
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

7.  Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary.

Authors:  Bálint Tresó; Erzsébet Barcsay; Anna Tarján; Gergely Horváth; Agnes Dencs; Andrea Hettmann; Mária Magdolna Csépai; Zoltán Gyori; Erzsébet Rusvai; Mária Takács
Journal:  J Urban Health       Date:  2012-02       Impact factor: 3.671

8.  Predictors of reincarceration and disease progression among released HIV-infected inmates.

Authors:  Jacques Baillargeon; Thomas P Giordano; Amy Jo Harzke; Anne C Spaulding; Z Helen Wu; James J Grady; Gwen Baillargeon; David P Paar
Journal:  AIDS Patient Care STDS       Date:  2010-06       Impact factor: 5.078

9.  Drug arrests and injection drug deterrence.

Authors:  Samuel R Friedman; Enrique R Pouget; Sudip Chatterjee; Charles M Cleland; Barbara Tempalski; Joanne E Brady; Hannah L F Cooper
Journal:  Am J Public Health       Date:  2010-12-16       Impact factor: 9.308

10.  Hepatitis C seroprevalence among prison inmates since 2001: still high but declining.

Authors:  Aiden K Varan; Daniel W Mercer; Matthew S Stein; Anne C Spaulding
Journal:  Public Health Rep       Date:  2014 Mar-Apr       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.